|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02373 BEAUTYFARM MED
Nominal 
16.840 +0.140 (+0.838%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,572,199 | 19.912% | 2,145,068 | 1,635,414 | 1,780,740 | 1,503,296 |
| Cost of Sales | (1,382,204) | 18.343% | (1,167,966) | (917,572) | (946,954) | (803,272) |
| Gross Profit | 1,189,995 | 21.788% | 977,102 | 717,842 | 833,786 | 700,024 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,021) | 279.523% | (796) | (155) | (1,306) | 2,015 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (51) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 317,883 | 10.273% | 288,269 | 130,475 | 255,102 | 188,531 | |
| Taxation | (65,405) | 12.515% | (58,130) | (19,943) | (46,761) | (36,346) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (24,018) | 65.847% | (14,482) | (7,423) | (14,866) | (1,226) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 228,460 | 5.937% | 215,657 | 103,109 | 193,475 | 150,959 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 3,941 | 32.515% | 2,974 | 21,619 | 22,933 | 24,794 |
| Depreciation & Amortisation | -- | -- | 331,736 | 297,241 | 275,188 | 259,249 |
| Directors' Emoluments | -- | -- | 3,244 | 6,124 | 4,381 | 1,754 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 99.000 | 5.319% | 94.000 | 52.000 | -- | -- |
| DPS (cts) | 48.000 | -- | 43.000 | 34.000 | -- | -- |
| Dividend Payout Ratio (%) | 48.485% | -- | 45.745% | 65.385% | -- | -- |
| Cash flow per share ($) | -- | -- | 2.736 | 1.911 | -- | -- |
| NBV per share ($) | 4.006 | -- | 3.392 | -- | -- | -- |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 228,460 |
| %Change | 5.937% |
| EPS / (LPS) | RMB 0.990 |
| NBV Per Share (¥) | RMB 4.006 |